NCT05077306 (MADC-19) is a NA clinical trial of music therapy group in SARS-CoV2 Infection, sponsored by Azienda Ospedaliero-Universitaria Consorziale Policlinico di Bari.

Who is sponsoring NCT05077306?

NCT05077306 is sponsored by Azienda Ospedaliero-Universitaria Consorziale Policlinico di Bari.

What drugs are being tested in NCT05077306?

Interventions in NCT05077306: music therapy group.

What condition does NCT05077306 study?

NCT05077306 studies SARS-CoV2 Infection.

Is NCT05077306 still recruiting?

NCT05077306 is currently completed. Last updated 14 October 2021.

Last reviewed 2021-10-14 · How we verify

NCT05077306: MADC-19

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Receptive Music Therapy on Anxiety and Vital Parameters in Hospitalized Covid-19 Patients.

Completed NA Last updated 14 October 2021

What this trial tests

NA trial testing music therapy group in SARS-CoV2 Infection in 40 participants. Completed in 30 June 2021.

Timeline

15 April 2021

Primary endpoint
15 May 2021

30 June 2021

Quick facts

Lead sponsor	Azienda Ospedaliero-Universitaria Consorziale Policlinico di Bari
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	none
Primary purpose	supportive care
Enrollment	40
Start date	15 April 2021
Primary completion	15 May 2021
Estimated completion	30 June 2021
Sites	1 location across Italy

Drugs / interventions tested

music therapy group

Conditions studied

SARS-CoV2 Infection — all drugs for SARS-CoV2 Infection →

Sponsor

Azienda Ospedaliero-Universitaria Consorziale Policlinico di Bari

Who can join

18 and older, any sex, with SARS-CoV2 Infection. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Hospitalized patients for Covid-19 are extremely isolated from their families for a long and uncertain period of time .This traumatic separation makes patients vulnerable to different degrees of stress disorders as well as depression and anxiety , fear of the unknown and dying, sleeplessness, agitation, discomfort, pain, immobility, frustration and inability to relax . MusicTtherapy has been shown to play a valuable role in the care of patients with serious illness, helping to address physical symptoms and psychological distress . The aim of this study was to evaluate the feasibility of introducing Music therapy (MT) on site with Covid-19 patients as a supporting complementary/non-pharmacological intervention, to investigate the immediate effects a single MT session has on anxiety, heart rate (HR), oxygen saturation (O2Sat) and satisfaction compared to standard care. In order to verify the hypotheses of the study, an RCT (mixed-methods approach pre -post design) will be carried out on patients diagnosed with SARS-COV2 admitted to Covid Hospital Bari, randomized into two groups: control group (B) and treatment group (A). . The study starts on 15th April 2021 and it is expected to run for 1 mounth (15th May 2021). The study is funding by University of Bari.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Effect of single session receptive music therapy on anxiety and vital parameters in hospitalized Covid-19 patients: a randomized controlled trial.
Giordano F, Losurdo A, Quaranta VN, Campobasso N, et al · · 2022 · cited 15× · PMID 35210504 · DOI 10.1038/s41598-022-07085-8

Verify or expand the search:

Other recruiting trials for SARS-CoV2 Infection

Currently open trials in the same condition.

NCT05852873 — PAxlovid loNg cOvid-19 pRevention triAl With recruitMent In the Community in Norway · Phase 3 · active not recruiting
NCT04910269 — Outpatient Treatment With Anti-Coronavirus Immunoglobulin · Phase 3 · recruiting
NCT04830852 — Pediatric COVID Outcomes Study (PECOS) · active not recruiting
NCT04844242 — MISC COVID-19 Study in Pediatric Population · recruiting

Other Azienda Ospedaliero-Universitaria Consorziale Policlinico di Bari trials

Trials by the same sponsor.

NCT06812611 — Effects of High Intensity Laser Therapy in Muscle Injuries · NA · recruiting
NCT07566507 — High-Energy Laser in the Conservative Treatment of Rhizarthrosis · NA · recruiting
NCT06833372 — Shock Waves in Knee Arthritis · NA · recruiting
NCT06737601 — ESWT vs Orthosis in Trigger Finger · NA · not yet recruiting
NCT07185555 — Vey Low-Energy Ketogenic Therapy in Adults With Type 1 Diabetes and Obesity on Intensive Insulin Therapy Using Advanded · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05077306 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Azienda Ospedaliero-Universitaria Consorziale Policlinico di Bari
Last refreshed: 14 October 2021

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05077306.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing